Market Tracker

01/23 11:53am ET

Dynavax Technologies Corp (NASDAQ:DVAX)

4.10
Delayed Data
As of 11:38am ET
 -0.15 / -3.53%
Today’s Change
3.20
Today|||52-Week Range
27.92
+3.80%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close4.25
Today’s open4.20
Day’s range4.05 - 4.30
Volume565,982
Average volume (3 months)1,783,715
Market cap$163.7M
Dividend yield--
Data as of 11:38am ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)+5.80%
Earnings growth (this year)+1.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-63.29%
P/E ratioNM
Price/Sales196.15
Price/Book0.87

Competitors

 Today’s
change
Today’s
% change
DRRXDURECT Corp+0.01+0.85%
OPHTOphthotech Corp-0.15-3.15%
NBRVNabriva Therapeutics...+0.03+0.39%
CEMPCempra Inc-0.13-4.17%
Data as of 11:53am ET, 01/23/2017

Financials

Next reporting dateMarch 14, 2017
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$4.1M
Annual profit (last year)-$106.8M
Net profit margin-2,636.89%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts